Skip to Content

Menu

Latest Articles and Media

Browse the latest blogs, podcasts, videos and journal articles from experts around the world.

Recommended For You

Please wait while we gather your results.

Ataxia Series: Treating cerebellar ataxia in 2026 - What's new?

Prodromal autonomic dysfunction in Lewy body diseases

Ataxia Series: Beyond the cerebellum - Non-motor features and multisystem care in genetic ataxias

Modulating the peripheral immune response: LRRK2 and GBA1 mutations

Ataxia Series: Neuroimaging patterns not to miss in ataxia

What is it? A young boy with deafness and twisting limb movements

Ataxia Series: Recognizing sporadic ataxias

History of Movement Disoders: The influence of videography

Ataxia Series: Deconstructing late-onset idiopathic ataxia

Rethinking Parkinson’s: The Somato-Cognitive Action Network (SCAN) hypothesis

Ataxia Series: The ataxia exam - Phenomenology, classification, and a practical diagnostic roadmap

Long-Term Follow-Up of Patients with Mass Social Media-Induced Illness Presenting with Functional Tic-like Behaviors

Revisiting the 2015 MDS clinical diagnostic criteria for Parkinson's disease

Distinguishing functional from idiopathic dystonia: A novel approach

What is it? Exercise-induced episodic gait disorder in a young boy

CSF proenkephalin as a biomarker for premotor Huntington's disease

Shame in Parkinson's disease: An unseen burden

Pregnancy and Parkinson’s disease: Navigating care before, during, and after

Effects of a probiotic on Parkinson's disease symptoms

History of Movement Disorders: Jean-Martin Charcot

Hot Topic: Integrating palliative care into routine care for patients with movement disorders

Waveform-based analysis of head tremor using a marker-less tracking algorithm with 2D-video

A lifetime of experiences and learnings - MDS 40th Anniversary

Collegiality and friendship - MDS 40th Anniversary

Promoting diversity and access to care and education - MDS 40th Anniversary

The lasting impacts of scholarly debates - MDS 40th Anniversary

Hot Topic: Palliative care in movement disorders

Hematopoietic stem cell transplantation in CSF1R-related disorder

Using alcohol as a tool to unravel laryngeal dystonia: The Vodka Trial

Safety and Tolerability of Bemdaneprocel in People with Parkinson’s Disease: Results up to 24 Months from a Phase 1 Study

Refining the MDS Disease Psychosis Rating Scale (MDS-PDPRS): Cognitive Interview Results from an International Study

Poststroke Movement Disorders: An International Multicentre Study

Phase 2 Study of ATH434 in MSA - α-Synuclein Aggregation, Imaging Biomarkers, and Severity

MDS Task Force on Tic Disorders: Development of a New Classification Scheme for Tic Disorders

Loneliness Accelerates Parkinsonism Decline in Parkinsonian Community-Dwelling Older Adults

Advancing MDS Guidelines for Electronic Clinical Outcome Assessments: Best Practices

Bridging the Digital Gap: A Global Survey of Technology Adoption by the MDS Technology Study Group

Critical Appraisal of MDS Criteria for Diagnosing PD

MDJ Review of the Year: "Deep Genotyping" - What third-generation sequencing can teach us

MDJ Research Article of the Year: Microglial activation in isolated REM sleep behavior disorder

Highlights for dystonia • 2025 MDS Congress

Current status of functional neurosurgery • 2025 MDS Congress

Current microbiome research for Parkinson's disease • 2025 MDS Congress

What’s new for MSA? • 2025 MDS Congress

What's next? Updates in functional neuroimaging • 2025 MDS Congress

Highlights in ataxia • 2025 MDS Congress

Breaking down functional movement disorders • 2025 MDS Congress

Current landscape of pediatric movement disorders • 2025 MDS Congress

Disease modification and Parkinson’s disease: Clinical trial design and population selection • 2025 MDS Congress

Motor rehabilitation for Parkinson’s disease • 2025 MDS Congress

Current genetic landscape for movement disorders • 2025 MDS Congress

Updates in tauopathies • 2025 MDS Congress

Achievements and future goals: An interview with MDS President • 2025 MDS Congress

What you missed: MDS Congress Day 4

What you missed: MDS Congress Day 3

What you missed: MDS Congress Day 2

What you missed: MDS Congress Day 1

Junior Awardee: Identifying a subthalamic nucleus cell subtype responsible for motor benefit in a Parkinsonian mouse model | Congress 2025

Junior Awardee: Mitochondrial and oligodendrocytic processes in MSA | Congress 2025

MDCP Research Article of the Year: Are hyposmia and REM sleep behavior disorder reliable indicators of Lewy body pathology?

MDCP Review of the Year: Why should subacute sclerosing panencephalitis be on our radar?

Presidential Lecture Awardee: A career observing the brain in action | Congress 2025

Presidential Lecture Awardee: Holistic conceptualization of patients with chronic illness | Congress 2025

Decoding epilepsy dyskinesia syndrome: Clinical clues and genotypic spectrum

Hot Topic: Normal pressure hydrocephalus - Assessments for intervention, outcomes, and future directions

Hot Topic: Normal pressure hydrocephalus - Pathophysiology and controversies

Hot Topic: Normal pressure hydrocephalus - Clinical aspects and differential diagnosis

The cholinergic contribution to freezing of gait in Parkinson’s disease

The longest prospective study of pallidal DBS for isolated dystonia

Neurotrophic factors to restore dopaminergic terminals in Parkinson's disease: A viral vector-delivered genetic therapy

Do social workers play a role in preoperative evaluation for DBS?

Surprise neuropathological findings in LRRK2 mutation carriers

Artificial intelligence in the diagnostic approach of chronic ataxias

Prime editing - A future therapy for cortical myoclonus?

History of Movement Disorders: The story of MPTP and parkinsonism

Myoclonus dystonia: Motor & non-motor symptoms and the effect of DBS

Genetic testing in deep brain stimulation for Parkinson's disease

Is propriospinal myoclonus a functional movement disorder?

SCA3 & life in the countryside: Exploring the interplay between genetics and environment

Differential diagnosis of myoclonus

Intraventricular infusion of anaerobic dopamine

Electrophysiology with a focus on cortical myoclonus

What can the locus coeruleus tell us about cognition in Lewy body disorders?

Myoclonus new classification & treatment

Transmission of Misfolded α-Synuclein Protein in Lewy Body Diseases (2024)

Next Generation Phenotyping in Movement Disorders (2024)

Celebrating the Parkinson's community

Gender differences in DBS decision making

Use hormonal cues to identify Parkinson's in women

Recognizing shoulder stiffness to diagnose early Parkinson's disease

Recognize two key clues for identifying Wilson's disease

Key vocal characteristics in MSA

Irregular movements to watch for in MSA

Improve dual-task abilities in Parkinson's disease

A potential sign of Parkinson's disease before motor symptoms appear

Abnormal eye movements that may indicate early PSP

Addressing constipation with diet in Parkinson's

An often-misdiagnosed sign of Parkinson's disease

Differentiate between MSA-C and cerebellar and genetic ataxias

Differentiate PD and PSP based on cognitive function

Dystonic signs to watch for when identifying patients with MSA

How dysphagia symptoms differ in patients with MSA

How to help PD patients with palilalia communicate more clearly

How to recognize mirror movements in early PD

Imaging signs to consider when identifying PSP

Use arm swinging to identify Parkinson's disease

GLP-1 agonists in Parkinson’s disease: New evidence, new questions?

Oral History: Irene Litvan (2023)

Oral History: Alberto Albanese (2023)

Oral History: Pramod Pal (2023)

Oral History: Ali Shalash (2023)

Oral History: Steven Frucht (2023)

Oral History: Jonathan Carr (2023)

Oral History: Claudia Trenkwalder (2022)

Oral History: Marie Vidailhet (2022)

Oral History: Susan Fox (2022)

Oral History: Njideka Okubadejo (2022)

Oral History: Henrique Ferraz (2022)

From populations to precision medicine: Progress toward prevention in Parkinson’s disease (2023)

Accelerating and globalizing genetic discovery in Parkinson’s disease (2023)

Back to the future: Is the clinical phenomenologist obsolete? (2022)

Challenge to elucidate the pathomechanisms of Parkinson’s disease: From pathogenesis to biomarkers (2022)

Mitochondrial DNA copy number: A potential biomarker for Parkinson's disease progression

tDCS for Tourette syndrome

Are hyposmia and REM sleep behavior disorder reliable indicators of Lewy body pathology?

Combined habit reversal and acceptance and commitment therapies for tics

Immune, metabolic and tau markers in blood cells in progressive supranuclear palsy

Focused ultrasound for cervical dystonia

Hot Topic: Subcutaneous levodopa infusion

Vibrotactile foot stimulation for freezing of gait

Video-based machine learning for tic detection

Tremor Series: What's in store? The future of tremor research

2026 Regional Course Topics

Defining Parkinson's disease: where we are, where we are headed

Tremor Series: The novel pharmacological and surgical treatments for tremor

Tremor Series: What’s essential tremor?

Skin tau as a biomarker of Huntington's disease

Tremor Series: So common, so difficult: The phenomenology of tremor

World Movement Disorders Day: Stigma in pediatric movement disorders

World Movement Disorders Day: How to fight stigma in Parkinson's disease

World Movement Disorders Day: Stigma in movement disorders

Tremor Series: How do we shake? The pathophysiology of tremor

Transcutaneous spinal cord stimulation for essential tremor

Tremor Series: Why tremor?

MDJ Research Article of the Year: Harmonizing genetic testing for Parkinson's disease

An online mindfulness-based group intervention for tics

α-Synuclein Pathology Across Movement Disorders and Neurodegenerative Diseases by Seed Amplification Assay

Use of Machine Learning for Identification of Parkinson’s Disease and Mild Cognitive Impairment through Neuroimaging and Biofluid Biomarkers: A Study from the PPMI Cohort

Spinocerebellar Ataxia Type 4: A Novel Polyglycine Disease Caused by GGC Repeat Expansion in ZFHX3

Safety and Tolerability of Ecopipam in Tourette Syndrome with Psychiatric Comorbidities

Quantitative Measurements of α-Synuclein Seeds in Cerebrospinal Fluid Inform Diagnosis and Staging of Synucleinopathies

Pharmacological Neuromodulation with Intracerebroventricular Administration of Anaerobic Dopamine for Parkinson's Disease

Parkinson’s Disease Burden in Underserved Populations Across the U.S. in 2022

A Novel Continuous Quantitative Measurement of Cutaneous Phosphorylated Alpha-Synuclein in PD, MSA, and DLB

Acceptability and User Experience of the Electronic Versions of the MDS-UPDRS and MDS-NMS Scales

AI-based 3D Anthropometric Modeling for Automated Assessment and Grading of Dystonia Patients

Artificial Intelligence: A Potential Predictor of GBA1-Mutated Genotype in PD Patients?

Combined Application of Alpha-Synuclein and 4-Repeat Tau Seed Amplification Assays for the Differential Diagnosis of Parkinsonian Disorders

Deep Brain Stimulation Does Not Modify the Cognitive Trajectory of GBA-PD: A Longitudinal Study of the Italian PARKNET Cohort

Global Trend of Parkinson’s Disease in 38 OECD Countries from 1990-2019: An Insight from the GBD 2019

Better understanding functional movement disorders • 2024 MDS Congress

Which protein is it? Copathologies • 2024 MDS Congress

The evolution of tremor • 2024 MDS Congress

Genetic dystonias and understanding molecular pathways • 2024 MDS Congress

Updates in PSP and Atypical PD • 2024 MDS Congress

New genes and technologies for movement disorder genetics • 2024 MDS Congress

Biomarkers and basic science research • 2024 MDS Congress

What's new in the pathophysiology of Parkinson's disease? • 2024 MDS Congress

Past, present, future: An interview with MDS President • 2024 MDS Congress

What you missed: MDS Congress Day 4

What you missed: MDS Congress Day 3

What you missed: MDS Congress Day 2

What you missed: MDS Congress Day 1

MDCP Research Article of the Year: The Role of Levodopa Challenge in Predicting the Outcome of STN DBS

MDJ Review Article of the Year: Subjective Cognitive Complaints in Parkinson's Disease

Junior Awardee - Understanding the optimal brain fingerprint to improve DBS outcomes in Parkinson's disease | Congress 2024

Junior Awardee - SAA development for the differentiation of progressive supranuclear palsy and Parkinson's disease | Congress 2024

Presidential Lecture Awardee - The importance of alpha-synuclein research | Congress 2024

Presidential Lecture Awardee - Insight into clinical phenotyping and the role of AI | Congress 2024

Hot Topic: Pesticides and Parkinson's Disease 2

Hot Topic: Pesticides and Parkinson's Disease 1

Essential tremor and dystonia: the TITAN study

Long-term follow up of GPi-DBS in pediatric non-degenerative dystonia

Neurovascular health and Lewy body disorders, where is the connection?

Disentangling the Cognitive Effects of Acute Levodopa in Parkinson's Disease

Device-Aided Therapies

Fundamentals Series (17 Modules)

Exploring postural control in functional motor disorders using virtual reality

Is levodopa disease modifying? Long-term LEAP study follow-up

A post-hoc analysis of the Prasinezumab trial in early Parkinson's disease

Do subjective cognitive complaints predict future incident cognitive impairment in people with Parkinson's disease?

Lixisenatide in Parkinson's: A Diabetes Drug to Slow Disease Progression?

Functional Tic-Like Behaviors: A Common Comorbidity in Patients with Tourette Syndrome

Hot Topic: Limitations of phenomenology in functional movement disorders: what can we learn?

Understanding corticobasal syndrome: Clinical and neuroimaging characteristics to unlock the underlying pathology

Chorea Series: Exploring medical and surgical management for chorea

CSF1R-related disorder in China

Chorea Series: Approach to patients with acquired choreas

Hot Topic: Focused Ultrasound in Movement Disorders - Brain ablations as a therapeutic tool

Chorea Series: Update on therapies for Huntington's disease

A new pathway to find structural variations in inherited neurological cases - the SCA4 example

Chorea Series: Approach to patients with genetic choreas

Concomitant pathologies and their clinical impact in multiple system atrophy

Chorea Series: Phenomenology of Chorea

Biomarker Updates: The Parkinson's disease pandemic

Biomarker Updates: Ongoing pharmacological developments in Parkinson’s disease and related disorders

Biomarker Updates: The immune system in Parkinson’s disease

Biomarker Updates: A conversation on biomarkers and diagnostics of Parkinson's disease and related disorders

The wisdom of our mentors: clinical pearls in movement disorders

Hot Topic: Focused Ultrasound in Movement Disorders - Blood-Brain Barrier Opening

Pallidotomy for Focal and Hemidystonia

Hot Topic: Focused Ultrasound in Movement Disorders - Neuromodulation

Erythrocytic α-synuclein and spreading pathology in Parkinson’s disease

Mortality in Parkinson's disease: findings from a nationwide study from Finland

Local fields potentials can help DBS programming in Parkinson's disease in clinical practice

Deep brain stimulation for GBA-related Parkinson's disease: is it a reasonable option?

Family history and genetic Alzheimer's risk and ties to Parkinson's disease

Unravelling the progression of tremor in Parkinson's disease

Using EEG to Identify Parkinson's Subtypes

School for Neurology Residents

Hot Topic: Tissue-based biomarkers in Parkinson's disease

Schools for Young Neurologists

Aspen

Expanded and Independent Spanish Validation of the MDS Non-Motor Rating Scale

Hot topic: GP2 and underrepresented populations

Task-specific brain oscillatory activity in laryngeal dystonia

MDJ Review Article of the Year Award: How does DBS change the course of Parkinson's?

MDCP Review Article of the Year: Alpha-Synuclein Seed Amplification Assays in CSF

The Role of Levodopa Challenge in Predicting the Outcome of STN DBS

Sleep and Cognitive Decline | Congress 2023

Highlights in Tic and Stereotypies | Congress 2023

Updates in MDS Education | Congress 2023

The Basic Science Perspective on the Role of Alpha-Synuclein | Congress 2023

Updates in Tremor Treatments | Congress 2023

Highlights in Multiple System Atrophy Research | Congress 2023

Advancements in Dystonia Treatments | Congress 2023

Updates in Gene Therapy | Congress 2023

Heterogeneity of Parkinson's Disease | Congress 2023

The Basic Science Perspective on Future Therapeutic Targets | Congress 2023

Highlights in Progressive Supranuclear Palsy Research | Congress 2023

Presidential Perspective | Congress 2023

New loci for Parkinson disease is identified in Latin America cohorts

Award Article: Long duration levodopa response and neuroplasticity in Parkinson’s disease

Award Article: Have we forgotten what tics are?

Case Presentations

Perry Disease

Pleiotropy in Parkinson´s disease and Cancer: Is there an association between these entities?

Parkin Maintains Robust Pacemaking in Human iPSC-derived A9 Dopaminergic Neurons

Getting involved in the MDS: a fruitful relationship

A cross-sectional study of PPMI participants using alpha-synuclein seed amplification as a biomarker

Inflammation is an early feature of Parkinson's disease

Diagnosis of Late-Onset Wilson's Disease

International Parkinson and Movement Disorder Society Mission and Structure

Deep brain stimulation in Parkinson's disease with cognitive impairment: real-world evidence

History of Movement Disorders: The Finding of Alpha-Synuclein and Lewy Bodies

Hot topic: The gut microbiome in Parkinson's

Pathological Validation of 2022 MSA Criteria

Walking through the falls: understanding gait with wearable sensors in Parkinson's disease

Targeting alpha synuclein in early Parkinson's disease. Clinical trials and future perspectives

Dystonia Series: Current and future approaches to treatment of dystonia

Dystonia Series: Unraveling the neural routes of dystonia

Machine learning for drug repurposing: A novel approach to find new treatments for Parkinson's disease

Dystonia Series: Genetic landscape of dystonia

Clozapine in Parkinson's disease: Why, when and how?

Dystonia Series: Beyond “torsion": non-motor features of dystonia

Off-State Dyskinesias after GDNF Infusion in Parkinson's Disease

Dystonia Series: Pearls on diagnosis and phenomenology

Idiopathic Normal Pressure Hydrocephalus: Critical Review of Objective Findings

History of Movement Disorders: Huntington's Disease in Venezuela

Striatal Blood Brain Barrier Opening in Parkinson's Dementia

Deep brain stimulation for Parkinson's disease dementia: are we there yet?

The Genetic Landscape of Complex Childhood-Onset Hyperkinetic Movement Disorders

Can dogs diagnose Parkinson's disease?

Nosology and Cut-Off Values for Axial Postural Abnormalities in Parkinsonism

COVID-19 and the Risk of Parkinsonism

Highlights on Tremor Disorders | Congress 2022

Highlights on Parkinson’s Disease | Congress 2022

Advances in Supranuclear Palsy Research | Congress 2022

Updates on Dystonia | Congress 2022

New Technology in Movement Disorders | Congress 2022

Updates of Functional Movement Disorders | Congress 2022

Genetic Highlights in Movement Disorders | Congress 2022

Highlights in Neuroimaging | Congress 2022

Updates on Multiple System Atrophy Research | Congress 2022

Highlights on Tic Disorders - Congress 2022

Basic Science Updates in Movement Disorders | Congress 2022

Highlights in Movement Disorder Education | Congress 2022

An Interview with MDS President Francisco Cardoso | Congress 2022

Award Article: A Multi-Step Model of Parkinson's Disease Pathogenesis

Award Replay: MDS Criteria for the diagnosis of Multiple System Atrophy: New features and implications

Assessment Training

For Industry

My Courses

All Courses

Parkinson's disease and type 2 diabetes: Clinical impact and therapeutic implications

Implanted system for orthostatic hypotension in multiple-system atrophy

Measuring gait through brain metabolism in Parkinson's disease: How it can help understanding and treating gait disorders

Peer review: Past, present and future

MDS Criteria for the diagnosis of Multiple System Atrophy: New features and implications

Parkinson's disease medications during hospitalization

How not to conduct a peer review: Fatal, avoidable errors.

Update from the Synuclein Meeting 2022

The Ethics of Peer Review

Pesticide exposure and dream-enacting behavior

The role of young members in the peer review process

Unmet needs of women with Parkinson's disease: Gaps and controversies

Approach to reviewing a review article

Interactive Cases

Rasagiline in PD: Does it change disease progression? And how do we measure it?

How to review an original scientific article

Infectious agents as drivers of synucleinopathies?

Reviewing case reports and clinical series

Does glucocerebrosidase activity correlate with disease risk or phenotype severity in Parkinson's disease?

What are journal editors looking for in a good review?

Outreach Education

When to accept or decline an invitation to review

Bilateral focused ultrasound thalamotomy for essential tremor, is it safe?

Overview and core components of the peer review process

Neuropsychiatric features of punding and hobbyism in Parkinson's disease

Approach to neuroimaging in Parkinsonisms

Journal CME

Interactive

Coffee Break CME

Coffee Break CME

Device-Assisted Therapies

Fundamentals

Fundamentals

Tau imaging for the study of corticobasal syndrome: The first steps of in vivo neuropathology

Perampanel may reduce alpha-synuclein transmission in Parkinson's disease. A possible therapeutic target?

Swim for Parkinson: Swimming together to improve together

The most impactful paper related to movement disorders therapy in the 20th century

Variability of movement disorders: The influence of sensation

An interview with Claudia Trenkwalder | Congress 2021

Ways to improve neuroprotection in Parkinson’s disease (2021)

Opening the Pandora’s box of Parkinsonism (2021)

Blinded RT-QuIC analysis of alpha-synuclein biomarker in skin tissue from Parkinson's disease patients

TikTok tics

Cognitive and visuospatial abilities in dystonia

Autophagy in levodopa-induced dyskinesia: A new potential therapeutic target

Electroconvulsive therapy in movement disorders

Curriculum Tracks

Latest Articles and Media

Courses

Acetylcholine nuclei atrophy predicts gait changes in Parkinson's disease

Anxiety in parkinson's disease and its correlates in mri-based functional connectivity

Parkinsonian syndromes and Parkinson's subtypes: Will a single neuroimaging modality ever be enough?

Scar dancing syndrome

Neuroinflammation in Parkinson's disease

Neurofilament light chain in Parkinson's disease

Anti-inflammatory drugs use impacts the risk of developing PD in LRRK2 mutation carriers

The impact of COVID-19 on scientific research activities

Value of invivosynuclein deposits in Parkinson's disease - Asystematic review and metaanalysis

Randomized controlled trial of exercise on objective and subjective sleep in Parkinson's disease

Myoclonus is telling how our brain works (2020)

Deep brain stimulation for Parkinson, beyond motor improvement: Social and occupational outcomes

Interview with Dr. Jon Stoessl on Preprints in the COVID-Era

Diagnosing Parkinson’s Disease: From the Street to the Bench (2020)

Late-stage Parkinsonism: Do we know enough?

Interview with the president on the MDS activities during the COVID crisis

Practicing medicine in time of pandemic and future of Movement Disorders medical practice

How to manage Parkinson's disease and related disorders, and is there a link between COVID and PD?

Antibiotics and Parkinson's disease

Integrated therapy for functional movement disorders

Fine tuning DBS in Parkinson's disease. How much can we improve?

White matter changes in Huntington's disease

Parkinsonian syndromes and Parkinson's subtypes: Will a single neuroimaging modality ever be enough?

New technologies in movement disorders | Congress 2019

Parkinson's disease and Lewy body disorders | Congress 2019

Atypical Parkinsonisms | Congress 2019

Tic disorders and Tourette syndrome | Congress 2019

Tremor | Congress 2019

The treatment of upper limb tremor with botulinum toxin: An individualized approach

Dystonia | Congress 2019

Neuroimaging in movement disorders | Congress 2019

Huntington's disease | Congress 2019

Introduction and functional movement disorders | Congress 2019

Education at the MDS | Congress 2019

Definition and characteristics of early onset PSP: A different disease?

Oral History: Murat Emre (2019)

Oral History: Glenda Halliday (2019)

Oral History: Beamseok (BJ) Jeon (2019)

Oral History: Per Odin (2019)

Oral History: Pablo Martinez-Martin (2019)

Reduced penetrance of hereditary movement disorders (2019)

Leadership and mentorship: The partners of success (2019)

MDS PSP criteria in practice: From clinical phenotyping to pathological diagnosis

Iron imaging of substantia nigra in Parkinson's disease: A possible biomarker?

Patient vs. care partner assessment of cognitive disability in Parkinson's: Who's more accurate?

Long-term outcomes of focused ultrasound in essential tremor

When should dopaminergic treatment be initiated in Parkinson's disease?

Advanced therapies for Parkinson's disease: Are they all the same?

Is benign hereditary chorea really benign?

Movement Inquisitive

The Mediterranean diet in Parkinson's disease

Oral History: Ken Marek (2018)

Dystonia or dystonias: Hybrid wonder and mystery (2018)

3D human brain organoids: Towards a better disease mode (2018)

Oral History: Shu-Leong Ho (2018)

Oral History: Nobutaka Hattori (2018)

Oral History: John Rothwell (2018)

Oral History: Louis Tan (2018)

Oral History: Oscar Gershanik (2018)

Stanley Fahn, MD: The Revolutionary Treatment for PD That Almost Got Away: The Levodopa Story

Oral History: Karl Kieburtz (2017)

Oral History: Stewart Factor (2017)

Oral History: Ronald Pfeiffer (2017)

Oral History: Charles Adler (2017)

Oral History: Patrick McGeer (2017)

Oral History: Jon Stoessl (2017)

Oral History: Howard Hurtig (2017)

Oral History: Mark Stacy (2017)

Oral History: D. James Surmeier (2017)

How Saskatoon’s research has advanced Movement Disorders (2017)

Clues to disease mech from the types and patterns of cellular pathologies in the brain (2017)

Welcome from MDS President Dr. Christopher Goetz (2017)

From causes of selective neuronal vulnerability in PD to a phase III clinical trial (2016)

The many faces of pre-PD: Facts and mysteries (2016)

Oral History: Thomas Wichmann (2016)

Oral History: Paul Greene (2016)

Oral History: Jesse Cedarbaum (2016)

Oral History: Wolfgang Oertel (2016)

Oral History: Thomas Gasser (2016)

Oral History: Ruth Hagestuen (2016)

Oral History: Marcelo Merello (2016)

Oral History: Kapil Sethi (2016)

Oral History: Kailash Bhatia (2016)

Oral History: K. Ray Chaudhuri (2016)

Oral History: Cynthia Comella (2016)

Oral History: Christine Klein (2016)

Basal ganglia and pathophysiology: Puzzles, paradoxes and clues (2015)

The enigma of action tremor in the elderly (2015)

Oral History: Thomas Chase (2015)

Oral History: Anne Young (2015)

Oral History: Robert Rodnitzky (2015)

Oral History: Matthew Stern (2015)

Oral History: Jose Obeso (2015)

Oral History: John Nutt (2015)

Oral History: Daniel Tarsy (2015)

Oral History: Andres Lozano (2015)

Developing cell therapy for human neurodegenerative disease (2014)

Shakes, twists and jerks: Can we diagnose and treat them? (2014)

Oral History: Olle Lindvall (2014)

Oral History: Pierre Pollak (2014)

Oral History: Günther Deuschl (2014)

Oral History: Caroline Tanner (2014)

The signs of a neurologist (2013)

Parkinson's disease: The windmills of your mind (2013)

Oral History: Philip Thompson (2013)

Oral History: James Lance (2013)

Oral History: John Steele (2013)

Oral History: Eldad Melamed (2013)

Oral History: Niall Quinn (2013)

Oral History: Mark Hallett (2013)

Oral History: Mahlon DeLong (2013)

Oral History: Eduardo Tolosa (2013)

Oral History: Bhim Singhal (2013)

The edgelands of the shaking palsy (2012)

Using genetic analysis to get at the biology of Parkinson's disease (2012)

Oral History: Werner Poewe (2012)

Oral History: John Morris (2012)

Oral History: Peter Jenner (2012)

Oral History: Joseph Jankovic (2012)

Oral History: John Hardy (2012)

Oral History: Ira Shoulson (2012)

Oral History: C. Warren Olanow (2012)

Oral History: Alim Benabid (2012)

It's time to fix the broken system of genetic locus symbols: Parkinson's disease and dystonia as examples (2011)

The mitochondrial story of Parkinson's disease: From David Marsden's time up to now (2011)

The role of basal ganglia and subconsciousness (2011)

Oral History: Ali Rajput (2011)

Oral History: Donald Calne (2011)

Oral History: Serge Przedborski (2011)

Oral History: Anthony Lang (2011)

Oral History: Arvid Carlsson (2011)

Oral History: Andrew Lees (2011)

The fox, the hedgehog, MDS and the world's best-known neurologist? (2010)

Oral History: Yves Agid (2010)

Oral History: Roger Duvoisin (2010)

Oral History: Masaya Segawa (2010)

Oral History: Hiroshi Shibasaki (2010)

Oral History: Gerald Stern (2010)

Oral History: Alfredo Berardelli (2010)

Oral History: Stanley Fahn (2010)

The stress of misfolded proteins in aging and neurodegenerative disease (2009)

Oral History: Yoshikuni Mizuno (2009)

Oral History: Richard Morimoto (2009)

Oral History: Christopher Goetz (2009)

Oral History: Reiner Benecke (2009)

Outreach Grant Programs

Education

Contributions of Jean Martin Charcot in Movement Disorders (2009)

Dr. Leland Dibble Presentation in Sydney, Australia, June 2013

Marilia Pereira, RN, Presentation in Sydney, Australia, June 2013

Quick Opinion Please

19th International Congress of Parkinson's Disease and Movement Disorders Welcome Ceremony

Dr. Fay Horak Presentation in Stockholm, Sweden, June 2014

Junior Interview: Claudia Trenkwalder and Roy Alcalay (2015)

Junior Interview: Cynthia Comella and Maria Stamelou (2015)

Junior Interview: Guenther Deuschl and Carine Maurer (2015)

Junior Interview: Mark Hallett and Bettina Balint (2015)

Junior Interview: Mark Hallett and Susanne Schneider (2015)

Lunasa & The Brain - Music in the Animal World

Lunasa & The Brain - Musicians' Dystonia

Lunasa & The Brain - What is Talent? Part 1

Lunasa & The Brain - What is Talent? Part 2

Welcome from MDS President Oscar Gershanik (2015-2017)